ClearPoint Neuro (CLPT) Capital Expenditures (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,216.33% |
| Dec 31, 2025 | -75.38% |
| Sep 30, 2025 | 118.68% |
| Jun 30, 2025 | -50.27% |
| Mar 31, 2025 | -30.42% |
| Dec 31, 2024 | 2,091.67% |
| Dec 31, 2023 | -91.06% |
| Sep 30, 2023 | -27.24% |
| Jun 30, 2023 | 134.06% |
| Mar 31, 2023 | 253.85% |
| Dec 31, 2022 | -43.48% |
| Sep 30, 2022 | -9.21% |
| Jun 30, 2022 | 10.14% |
| Mar 31, 2022 | 81.58% |
| Dec 31, 2021 | -69.60% |
| Sep 30, 2021 | 457.14% |
| Jun 30, 2021 | -187.50% |
| Dec 31, 2018 | -92.48% |
| Sep 30, 2018 | -63.85% |
| Jun 30, 2018 | 49.43% |
| Sep 30, 2015 | 8,612.13% |
| Jun 30, 2015 | -88.82% |
| Mar 31, 2015 | -81.84% |
| Dec 31, 2014 | 488.20% |
| Sep 30, 2014 | 107.90% |
| Jun 30, 2014 | 25.02% |
| Mar 31, 2014 | 190.05% |
| Dec 31, 2013 | -95.37% |
| Sep 30, 2013 | -62.80% |
| Jun 30, 2013 | 499.27% |
| Mar 31, 2013 | -76.65% |
| Dec 31, 2012 | 307.35% |
| Sep 30, 2012 | -89.55% |
| Jun 30, 2012 | 1,677.04% |
| Mar 31, 2012 | -52.14% |
| Dec 31, 2011 | -36.67% |